跳至主要内容
临床试验/NCT02686606
NCT02686606已完成不适用

A Randomised Controlled Crossover Trial to Investigate the Effect of Different Oral Nutritional Supplements on Fluid and Sodium Status in Patients With Short Bowel Intestinal Failure

London North West Healthcare NHS Trust0 个研究点目标入组 10 人开始时间: 2016年1月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
10
主要终点
Change in faecal sodium

研究概览

简要总结

Patients with short bowel intestinal failure are recommended to aim for a diet high in energy and protein. Some patients have difficulties in achieving recommended intakes and additional nutrition may be provided by oral nutritional supplements. There is very little research completed on which is the best oral nutritional supplement for patients. The aim of the study is to see the effect different oral nutritional supplements have on your stoma or fistula output and levels of hydration.

详细描述

After written consent is obtained, patients will be asked to fast from 12.00am on day one. At 08.00am patients will be asked to pass urine and to empty their stoma bag. After this they will be asked to drink 200ml of the ONS which they have been randomised to test on day one over a 30 minute period. Urine and intestinal output will be collected into two separate containers over the next 6 hours. During this time the patient will not be permitted to eat or drink other fluids. After 6 hours the patient will be able to eat and drink normally. The urine and intestinal output will be weighed and then an aliquot will be stored in a -20oC freezer before being sent for analysis. Day two is a washout day when the patient will be able to eat and drink normally. Day three will be the same as day one but the patient will have the other ONS that they did not have on day one. No changes will be made to the patient's usual anti diarrhoeal and/or anti motility agents or parenteral support during the study.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 100 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Adult patients (>18 years)
  • Residual length of small bowel <200cm determined either at operation or radiologically.
  • Patients with a stoma or an established enterocutaneous fistula
  • Normal hydration status (urinary sodium >20mmol/L)

排除标准

  • Dehydration (urinary sodium <20mmol/L)
  • Patients with short bowel and a jejunocolonic anastomosis
  • Current sepsis of any cause
  • Addition/amendment to anti-diarrhoeal or anti motility agents in the last 3 days
  • Severe gastrointestinal obstruction or structural abnormality of the intestine
  • Active Crohn's disease - assessed using two of the three parameters:
  • CReactive Protein >10 Albumin <30g/L Platelets >400
  • Participation in another intervention trial which may affect intestinal absorption
  • Nil by mouth
  • Unable or unwilling to provide consent

结局指标

主要结局

Change in faecal sodium

时间窗: Day 1 and 3

Change in faecal sodium

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

相似试验